Advertisement

Topics

Tyme Technologies, Inc. Company Profile

14:54 EST 13th December 2018 | BioPortfolio

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the originator of what it believes to be a novel, proprietary treatment regimen consisting of a rationally-designed combination of therapeutic agents aimed at exploiting the aberrant metabolic characteristics of cancer cells as well as activating the endogenous immune response against tumors. Tyme, Inc.'s approach is hypothesized to permit selective elimination of cancer cells, while simultaneously improving patients' well-being, particularly with respect to pain severity and functional independence.


News Articles [243 Associated News Articles listed on BioPortfolio]

Tyme Technologies: Our Take On This $3 Biotech Concern

Tyme Technologies, Inc. Set to Join Russell 3000® Index

NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced it is set to...

Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019

NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical a...

Tyme Technologies, Inc. to Present at the Evercore ISI, HealthconX Conference on November 27th

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today annou...

Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th

NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today annou...

Tyme Technologies, Inc. and the Joseph Ahmed Foundation Announce Planned Trial for SM-88 in Ewing’s Sarcoma

Recognized sarcoma thought leader, Dr. Sant P. Chawla, will conduct the investigator-initiated Phase II studyThe Joseph Ahmed Foundation (“JAF”) will provide funding and patient support for the s...

Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will...

Tyme Provides Clinical and Corporate Update for Fiscal 2Q 2019

SM-88 to be included in pivotal Precision Promise pancreatic cancer trial led by Pancreatic Cancer Action Network (PanCAN) expected to commence in the first half of 2019 Interim data for SM-88 from ...

PubMed Articles [321 Associated PubMed Articles listed on BioPortfolio]

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Thymic epithelial tumors (TETs) are a heterogenous group of rare tumors, with a complex histopatological classification. Furthermore, the recent introduction of the first TNM staging system, that is s...

Adoption of Stroke Rehabilitation Technologies by the User Community: Qualitative Study.

Using technology in stroke rehabilitation is attractive. Devices such as robots or smartphones can help deliver evidence-based levels of practice intensity and automated feedback without additional la...

Application of Digital Technologies in Maxillofacial Prosthetics Literature: A 10-Year Observation of Five Selected Prosthodontics Journals.

To identify trends in the application of various types of digital technologies in maxillofacial prosthetics by identifying these digital technologies and their characteristics and reviewing the preval...

What do we know about technologies for dementia-related wandering? A scoping review: Examen de la portée : Que savons-nous à propos des technologies de gestion de l'errance liée à la démence?

Occupational therapists use technologies to manage wandering-related risks to promote safety and independence among individuals with dementia living in the community.

Graphics and Media Technologies for Operators in Industry 4.0.

Visual computing technologies have an important role in manufacturing and production, particularly in new Industry 4.0 scenarios with intelligent machines, human-robot collaboration and learning facto...

Clinical Trials [458 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1284 Associated Companies listed on BioPortfolio]

Tyme Technologies, Inc.

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the origi...

Tyme, Inc.

Tyme is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme is the originator of wha...

Tyme Technologies Inc.

Tyme Technologies, Inc.

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

More Information about "Tyme Technologies, Inc." on BioPortfolio

We have published hundreds of Tyme Technologies, Inc. news stories on BioPortfolio along with dozens of Tyme Technologies, Inc. Clinical Trials and PubMed Articles about Tyme Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tyme Technologies, Inc. Companies in our database. You can also find out about relevant Tyme Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record